TABLE 2.
Pathway analysis of metabolites from C10-treated vs CTR cells.
| Pathway name | Match status | p-value | Impact |
| Purine metabolism | 1/65 | 1.7051E-5 | 0.0 |
| Pyrimidine metabolism | 1/39 | 1.7051E-5 | 0.0 |
| D-Glutamine and D-glutamate metabolism | 3/6 | 3.6167E-4 | 0.5 |
| Aminoacyl-tRNA biosynthesis | 6/48 | 8.2099E-4 | 0.0 |
| Starch and sucrose metabolism | 1/18 | 0.0020341 | 0.4207 |
| Galactose metabolism | 1/27 | 0.0020341 | 0.03499 |
| Neomycin, kanamycin and gentamicin biosynthesis | 1/2 | 0.0020341 | 0.0 |
| Nitrogen metabolism | 2/6 | 0.0024727 | 0.0 |
| Alanine, aspartate and glutamate metabolism | 10/28 | 0.012493 | 0.67629 |
| Glyoxylate and dicarboxylate metabolism | 7/32 | 0.015648 | 0.13493 |
| Arginine biosynthesis | 5/14 | 0.022856 | 0.11675 |
| Propanoate metabolism | 3/23 | 0.026032 | 0.04061 |
| Citric acid cycle | 7/20 | 0.032615 | 0.41976 |
| Pyruvate metabolism | 5/22 | 0.039236 | 0.2395 |
Pathways involved in C-10 treated cells with the number of metabolites that match in the indicated pathway; p is the original p-value calculated from the Enrichment Analysis; impact is the pathway impact value calculated from pathway topology analysis.